• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CGEN:IT

3,133.00 ILs 56.00 1.76%

As of 07:24:45 ET on 04/17/2014.

Snapshot for Compugen Ltd (CGEN)

Open: 3,196.00 Day's Range: 3,101.00 - 3,196.00 Volume: 49,410
Previous Close: 3,189.00 52wk Range: 1,850.00 - 4,740.00 1-Yr Rtn: +68.71%

Stock Chart for CGEN

No chart data available.
  • CGEN:IT 3,150.00
  • 1D
  • 1M
  • 1Y
3,189.00
Interactive CGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -1.2996
Est. EPS (USD) (12/2014) -0.2900
Est. PEG Ratio -
Market Cap (M ILS) 1,513.47
Shares Outstanding (M) 48.31
30 Day Average Volume 212,527
Price/Book (mrq) 11.6241
Price/Sale (ttm) 97.4593
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CGEN

Compugen Ltd. develops solutions in the field of computational genomics. The Company provides its gene discovery tools to pharmaceutical, biotechnology, and other life sciences through its Web site, labOnWeb.com. Compugen is also seeking to commercialize the genes and proteins it discovers.

Anat Cohen-DayagPresident/CEODikla Czaczkes AxselbardChief Financial Officer
John J HunterVP:Antibody Research & Dev
More Company Profile & Key Executives for CGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil